Simplex Trading’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-182,900
| Closed | -$556K | – | 10005 |
|
|
2024
Q4 | $556K | Buy |
182,900
+90,300
| +98% | +$393K | ﹤0.01% | 3412 |
|
|
2024
Q3 | $480K | Sell |
92,600
-9,300
| -9% | -$46.2K | ﹤0.01% | 3630 |
|
|
2024
Q2 | $261K | Sell |
101,900
-84,400
| -45% | -$288K | ﹤0.01% | 4381 |
|
|
2024
Q1 | $916K | Buy |
186,300
+6,900
| +4% | +$40.8K | ﹤0.01% | 3214 |
|
|
2023
Q4 | $1.58M | Buy |
179,400
+137,900
| +332% | +$1.13M | ﹤0.01% | 2568 |
|
|
2023
Q3 | $476K | Sell |
41,500
-3,000
| -7% | -$57.7K | ﹤0.01% | 3460 |
|
|
2023
Q2 | $1.13M | Sell |
44,500
-4,700
| -10% | -$146K | ﹤0.01% | 2493 |
|
|
2023
Q1 | $1.58M | Buy |
49,200
+3,700
| +8% | +$115K | ﹤0.01% | 2148 |
|
|
2022
Q4 | $839K | Sell |
45,500
-39,900
| -47% | -$913K | ﹤0.01% | 2649 |
|
|
2022
Q3 | $2.31M | Buy |
85,400
+55,100
| +182% | +$1.12M | ﹤0.01% | 1835 |
|
|
2022
Q2 | $418K | Sell |
30,300
-35,700
| -54% | -$550K | ﹤0.01% | 3672 |
|
|
2022
Q1 | $1.29M | Buy |
66,000
+26,800
| +68% | +$406K | ﹤0.01% | 2600 |
|
|
2021
Q4 | $639K | Sell |
39,200
-700
| -2% | -$11.7K | ﹤0.01% | 3479 |
|
|
2021
Q3 | $1.22M | Hold |
39,900
| – | – | ﹤0.01% | 2801 |
|
|
2021
Q2 | $1.18M | Buy |
39,900
+39,777
| +32,339% | +$1.15M | ﹤0.01% | 2864 |
|
|
2021
Q1 | $343K | Sell |
123
-103
| -46% | -$2.85K | ﹤0.01% | 3962 |
|
|
2020
Q4 | $640K | Buy |
226
+102
| +82% | +$2.64K | ﹤0.01% | 3114 |
|
|
2020
Q3 | $311K | Sell |
124
-255
| -67% | -$6.69K | ﹤0.01% | 3560 |
|
|
2020
Q2 | $925K | Buy |
379
+2
| +0.5% | +$39 | ﹤0.01% | 2219 |
|
|
2020
Q1 | $557K | Buy |
377
+286
| +314% | +$5.92K | ﹤0.01% | 2482 |
|
|
2019
Q4 | $147K | Buy |
91
+25
| +38% | +$388 | ﹤0.01% | 4088 |
|
|
2019
Q3 | $85K | Buy |
66
+43
| +187% | +$526 | ﹤0.01% | 4499 |
|
|
2019
Q2 | $29K | Sell |
23
-83
| -78% | -$1.05K | ﹤0.01% | 5313 |
|
|
2019
Q1 | $167K | Buy |
106
+73
| +221% | +$1.27K | ﹤0.01% | 3798 |
|
|
2018
Q4 | $66K | Sell |
33
-88
| -73% | -$1.94K | ﹤0.01% | 4266 |
|
|
2018
Q3 | $300K | Sell |
121
-85
| -41% | -$2.31K | ﹤0.01% | 3179 |
|
|
2018
Q2 | $565K | Sell |
206
-14
| -6% | -$421 | ﹤0.01% | 2343 |
|
|
2018
Q1 | $8K | Sell |
220
-445
| -67% | -$14.3K | ﹤0.01% | 4251 |
|
|
2017
Q4 | $204K | Buy |
665
+651
| +4,650% | +$18.7K | 0.01% | 1260 |
|
|
2017
Q3 | $8K | Sell |
14
-20
| -59% | -$485 | ﹤0.01% | 4022 |
|
|
2017
Q2 | $19K | Buy |
+34
| New | +$758 | ﹤0.01% | 3362 |
|
|
2016
Q1 | – | Sell |
-352
| Closed | -$29K | – | 6392 |
|
|
2015
Q4 | $29K | Buy |
352
+341
| +3,100% | +$11.8K | ﹤0.01% | 2391 |
|
|
2015
Q3 | $6K | Sell |
11
-15
| -58% | -$456 | ﹤0.01% | 3890 |
|
|
2015
Q2 | $25K | Buy |
+26
| New | +$669 | ﹤0.01% | 2273 |
|
Other funds holding RVNC
Simplex Trading's RVNC Position: Q1 2025 in Review
Simplex Trading sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 38,598 shares — an estimated $117K sold.
Simplex Trading first reported a position in RVNC in Q3 2015 and held it in 25 quarters. The position peaked at $1.28M in Q3 2022. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.
- Simplex Trading reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
- Simplex Trading sold 38,598 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $117K.
- Simplex Trading first reported a position in Revance Therapeutics, Inc. in Q3 2015 and held it in 25 quarters.
- Simplex Trading's Revance Therapeutics, Inc. position peaked at $1.28M in Q3 2022.
- 1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.
Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.